Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC1445143576;43577;43578 chr2:178632655;178632654;178632653chr2:179497382;179497381;179497380
N2AB1281038653;38654;38655 chr2:178632655;178632654;178632653chr2:179497382;179497381;179497380
N2A1188335872;35873;35874 chr2:178632655;178632654;178632653chr2:179497382;179497381;179497380
N2B538616381;16382;16383 chr2:178632655;178632654;178632653chr2:179497382;179497381;179497380
Novex-1551116756;16757;16758 chr2:178632655;178632654;178632653chr2:179497382;179497381;179497380
Novex-2557816957;16958;16959 chr2:178632655;178632654;178632653chr2:179497382;179497381;179497380
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: D
  • RefSeq wild type transcript codon: GAC
  • RefSeq wild type template codon: CTG
  • Domain: Ig-95
  • Domain position: 44
  • Structural Position: 111
  • Q(SASA): 0.7052
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
D/N rs768931150 0.276 0.993 N 0.613 0.373 0.464442853059 gnomAD-2.1.1 4.03E-06 None None None None N None 0 2.9E-05 None 0 0 None 0 None 0 0 0
D/N rs768931150 0.276 0.993 N 0.613 0.373 0.464442853059 gnomAD-4.0.0 3.42159E-06 None None None None N None 0 2.23654E-05 None 0 0 None 0 3.47102E-04 8.99603E-07 1.15942E-05 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
D/A 0.1596 likely_benign 0.162 benign 0.044 Stabilizing 0.977 D 0.523 neutral N 0.505764972 None None N
D/C 0.5404 ambiguous 0.5473 ambiguous -0.045 Destabilizing 1.0 D 0.733 prob.delet. None None None None N
D/E 0.1145 likely_benign 0.1118 benign -0.257 Destabilizing 0.117 N 0.321 neutral N 0.470216411 None None N
D/F 0.5582 ambiguous 0.5365 ambiguous -0.107 Destabilizing 1.0 D 0.708 prob.delet. None None None None N
D/G 0.1084 likely_benign 0.1141 benign -0.053 Destabilizing 0.977 D 0.551 neutral N 0.509900253 None None N
D/H 0.2267 likely_benign 0.2194 benign 0.452 Stabilizing 0.999 D 0.637 neutral N 0.511392063 None None N
D/I 0.3337 likely_benign 0.3343 benign 0.231 Stabilizing 0.998 D 0.719 prob.delet. None None None None N
D/K 0.2297 likely_benign 0.2399 benign 0.456 Stabilizing 0.99 D 0.564 neutral None None None None N
D/L 0.3536 ambiguous 0.3576 ambiguous 0.231 Stabilizing 0.995 D 0.693 prob.neutral None None None None N
D/M 0.5932 likely_pathogenic 0.573 pathogenic 0.086 Stabilizing 1.0 D 0.715 prob.delet. None None None None N
D/N 0.0937 likely_benign 0.094 benign 0.304 Stabilizing 0.993 D 0.613 neutral N 0.507624979 None None N
D/P 0.542 ambiguous 0.534 ambiguous 0.187 Stabilizing 0.998 D 0.591 neutral None None None None N
D/Q 0.2549 likely_benign 0.2505 benign 0.293 Stabilizing 0.99 D 0.663 neutral None None None None N
D/R 0.2616 likely_benign 0.2653 benign 0.631 Stabilizing 0.995 D 0.625 neutral None None None None N
D/S 0.1017 likely_benign 0.1037 benign 0.191 Stabilizing 0.983 D 0.557 neutral None None None None N
D/T 0.2211 likely_benign 0.2195 benign 0.271 Stabilizing 0.995 D 0.58 neutral None None None None N
D/V 0.2056 likely_benign 0.212 benign 0.187 Stabilizing 0.997 D 0.687 prob.neutral D 0.622489609 None None N
D/W 0.837 likely_pathogenic 0.8296 pathogenic -0.091 Destabilizing 1.0 D 0.741 deleterious None None None None N
D/Y 0.2255 likely_benign 0.2263 benign 0.111 Stabilizing 1.0 D 0.708 prob.delet. D 0.624220697 None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.